Stay updated on THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Sign up to get notified when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.

Latest updates to the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page
- CheckyesterdayChange DetectedA new revision label v3.7.0 was added. The previous revision label v3.6.6 was removed.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page shows a new revision label, updating from v3.6.5 to v3.6.6, which indicates a minor update to the page or its underlying system. This change does not introduce any visible content changes to the user.SummaryDifference0.0%

- Check22 days agoChange DetectedThe study identifiers section now includes '2016 ( U.S. NIH Grant/Contract )', indicating NIH funding for the THALES trial. This addition does not modify the study content or how a user would interact with the page.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This represents a minor update to the page's documentation/version tracking rather than substantive content changes.SummaryDifference0.0%

- Check50 days agoChange DetectedThe study location entry for Zaporizhzhia is updated to Zaporizhzhya with two site codes (69068 and 69600), replacing the previous spelling. The page revision is updated from v3.6.3 to v3.6.4.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page now displays Revision: v3.6.3 in place of Revision: v3.6.0, indicating a small underlying update to the page.SummaryDifference0.0%

Stay in the know with updates to THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.